Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.
作者信息
Cheng Matthew P, Lee Todd C, Tan Darrell H S, Murthy Srinivas
机构信息
Division of Infectious Diseases (Cheng, Lee), Department of Medicine, and Division of Medical Microbiology (Cheng), Department of Laboratory Medicine, McGill University Health Centre; Clinical Trials Platform (Cheng, Lee), McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, Que.; Division of Infectious Diseases (Tan) and MAP Centre for Urban Health Solutions (Tan), St. Michael's Hospital; Department of Medicine (Tan), University of Toronto, Toronto, Ont.; Department of Pediatrics (Murthy), University of British Columbia, Vancouver, BC.
Division of Infectious Diseases (Cheng, Lee), Department of Medicine, and Division of Medical Microbiology (Cheng), Department of Laboratory Medicine, McGill University Health Centre; Clinical Trials Platform (Cheng, Lee), McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, Que.; Division of Infectious Diseases (Tan) and MAP Centre for Urban Health Solutions (Tan), St. Michael's Hospital; Department of Medicine (Tan), University of Toronto, Toronto, Ont.; Department of Pediatrics (Murthy), University of British Columbia, Vancouver, BC
出版信息
CMAJ. 2020 Apr 14;192(15):E405-E407. doi: 10.1503/cmaj.200438. Epub 2020 Mar 26.
Abstract
摘要
相似文献
1
Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.
CMAJ. 2020 Apr 14;192(15):E405-E407. doi: 10.1503/cmaj.200438. Epub 2020 Mar 26.
2
Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions.
Ann Intern Med. 2020 Oct 6;173(7):576-577. doi: 10.7326/M20-2933. Epub 2020 Jun 11.
3
Drug Evaluation during the Covid-19 Pandemic.
N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14.
4
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
5
Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
JAMA. 2020 Oct 6;324(13):1282-1283. doi: 10.1001/jama.2020.16253.
6
Optimizing the Trade-off Between Learning and Doing in a Pandemic.
JAMA. 2020 May 19;323(19):1895-1896. doi: 10.1001/jama.2020.4984.
7
Dexamethasone in the management of covid -19.
BMJ. 2020 Jul 3;370:m2648. doi: 10.1136/bmj.m2648.
8
Does hydroxychloroquine combat COVID-19? A timeline of evidence.
J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.
9
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
Ann Intern Med. 2020 Jun 2;172(11):754-755. doi: 10.7326/M20-1334. Epub 2020 Mar 31.
10
No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.
Am J Bioeth. 2020 Sep;20(9):W1-W4. doi: 10.1080/15265161.2020.1805525.
引用本文的文献
1
Asymptomatic testing people for SARS-CoV-2 in healthcare facilities: A systematic review.
J Public Health Afr. 2025 Jan 3;16(2):581. doi: 10.4102/jphia.v16i2.581. eCollection 2025.
2
Long COVID clinics and services offered by top US hospitals: an empirical analysis of clinical options as of May 2023.
BMC Health Serv Res. 2024 May 30;24(1):684. doi: 10.1186/s12913-024-11071-3.
3
Impact of Allocation Concealment and Blinding in Trials Addressing Treatments for COVID-19: A Methods Study.
Am J Epidemiol. 2023 Oct 10;192(10):1678-1687. doi: 10.1093/aje/kwad131.
4
Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.
Health Res Policy Syst. 2022 Sep 10;20(1):99. doi: 10.1186/s12961-022-00883-6.
5
Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From to Validation.
Front Microbiol. 2022 May 4;13:757418. doi: 10.3389/fmicb.2022.757418. eCollection 2022.
6
Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
Cells. 2022 Mar 31;11(7):1182. doi: 10.3390/cells11071182.
7
Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists.
PLoS One. 2022 Jan 21;17(1):e0261843. doi: 10.1371/journal.pone.0261843. eCollection 2022.
8
Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change.
Ethics Hum Res. 2021 Nov;43(6):19-27. doi: 10.1002/eahr.500107. Epub 2021 Oct 26.
9
[Recommendations for use of the diverse tests for detection of SARS-COV-2 infection].
Enferm Clin. 2021 Feb;31:S40-S48. doi: 10.1016/j.enfcli.2020.10.001. Epub 2020 Oct 14.
10
Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials.
BMC Med Res Methodol. 2021 Apr 30;21(1):91. doi: 10.1186/s12874-021-01291-0.
本文引用的文献
1
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
2
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
3
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
4
What did we learn from Tamiflu?
BMJ. 2020 Feb 19;368:m626. doi: 10.1136/bmj.m626.
5
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
6
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27.
7
What the public think about participation in medical research during an influenza pandemic: an international cross-sectional survey.
Public Health. 2019 Dec;177:80-94. doi: 10.1016/j.puhe.2019.07.005. Epub 2019 Sep 23.
8
A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals.
Elife. 2019 Jun 11;8:e45183. doi: 10.7554/eLife.45183.
9
Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries.
Health Expect. 2018 Feb;21(1):387-395. doi: 10.1111/hex.12634. Epub 2017 Sep 27.
10
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
Zotero 插件